Emricasan
Emricasan (IDN-6556; PF-03491390) is a potent, irreversible pan-caspase inhibitor, shows neuroprotective activity for hNPCs, inhibits ZIKV-induced increased caspase-3 activity.Steatohepatitis Phase 2 Clinical.
Product Specifications
CAS Number
254750-02-2
Product Name Alternative
IDN-6556 | PF-03491390
Purity
>98% (HPLC)
Solubility
DMSO: 93 mg/mL (163.3 mM) ; Ethanol: 93 mg/mL (163.3 mM) ; Water: <1 mg/mL (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
O=C (O) C[C@H] (NC ([C@H] (C) NC (C (NC1=CC=CC=C1C (C) (C) C) =O) =O) =O) C (COC2=C (F) C (F) =CC (F) =C2F) =O
Molecular Formula
C26H27F4N3O7
Molecular Weight
569.51
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(3S) -3-[[ (2S) -2-[[2- (2-tert-butylanilino) -2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5- (2,3,5,6-tetrafluorophenoxy) pentanoic acid
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog